13C urea breath test for Helicobacter pylori: Determination of the optimal cut-off point in a Canadian community population

Canadian Journal of Gastroenterology

Volumn 20, Issue 12, 2006, Pages 770-774

  Mauro, Marina ^a   Radovic, Vladimir ^a   Zhou, Pengfei ^a   Wolfe, Melanie ^a   Kamath, Markad ^a   Bercik, Premsyl ^a   Croitoru, Ken ^a   Armstrong, David ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

13 urea breath test; Cut off point; Helicobacter pylori

Indexed keywords

CARBON 13; UREA; CARBON; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CANADA; CLUSTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOSCOPIC BIOPSY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UREA BREATH TEST; VALIDITY; BIOPSY; BREATH ANALYSIS; DIFFERENTIAL DIAGNOSIS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; STOMACH MUCOSA;

BIOPSY; BREATH TESTS; CARBON ISOTOPES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; UREA;

EID: 33845872275     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/472837     Document Type: Article

References (30)

1. The EUROGAST Study Group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993;34:1672-6.
2. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
3. Rothenbacher D, Brenner H. Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: Recent developments and future implications. Microbes Infect 2003;5:693-703.
4. Frenck RW Jr, Clemens J. Helicobacter in the developing world. Microbes Infect 2003;5:705-13.
5. Hunt R, Fallone C, Veldhuyzen van Zanten S, et al; CHSG 2004 participants. Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori - an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection. Can J Gastroenterol 2004;18:547-54.
6. McColl KE, el-Omar E. Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer. Scand J Gastroenterol 1996;215(Suppl 30:32-7.
7. Imrie C, Rowland M, Bourke B, Drumm B. Is Helicobacter pylori infection in childhood a risk factor for gastric cancer? Pediatrics 2001;107:373-80.
8. Malfertheiner P, Megraud F, O'Morain C, et al; European Helicobacter Pylori Study Group. Current concepts in the management of Helicobacter pylori infection - The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-80.
9. Logan RP. Breath tests used to detect Helicobacter pylori. In: Goodwin CS, Worsley BW, eds. Helicobacter pylori: Biology and Clinical Practice. Boca Raton: CRC Press, 1993:307-27.
10. Hunt RH, Fallone CA, Thomson AB; Canadian Helicobacter Study Group. Canadian Helicobacter pylori Consensus Conference update: Infections in adults. Can J Gastroenterol 1999; 13:213-7.
11. Suzuki H, Masaoka T, Nomura S, et al. Current consensus on the diagnosis and treatment of H pylori-associated gastroduodenal disease. Keio J Med 2003;52:163-73.
12. 13C-urea breath test. Lancet 1995;345:961-2.
13. 13C-urea breath test. Gastroenterol Clin North Am 2000; 29:885-93.
14. Perri F, Ricciardi R, Merla A, et al. Appropriateness of urea breath test: A prospective observational study based on Maastricht 2000 guidelines. Aliment Pharmacol Ther 2002;16:1443-7.
15. 13C-urea breath test value by nationality in Helicobacter pylori-infected children. Scand J Gastroenterol 1998;33:468-72.
16. 13C urea breath test in Japanese patients. Helicobacter 2000; 5:98-103.
17. Adachi K, Fujishiro H, Mihara T, Komazawa Y, Kinoshita Y. Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection. J Gastroenterol Hepatol 2003;18:168-71.
18. Lai YC, Wang TH, Huang SH, et al. Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers. World J Gastroenterol 2003;9:1537-40.
19. Veldhuyzen van Zanten SJ, Bradette M, Chiba N, et al; Canadian Dyspepsia Working Group. Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: An update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool. Can J Gastroenterol 2005;19:285-303.
20. Atherton JC, Spiller RC. The urea breath test for Helicobacter pylori. Gut 1994;35:723-5.
21. Slomianski A, Schubert T, Cutler AF. [13C]-urea breath test to confirm eradication of Helicobacter pylori. Am J Gastroenterol 1995;90:224-6.
22. Mion F, Rousseau M. Diagnostic test to document Helicobacter pylori eradication. Gastroenterology 1996;110:324-5.
23. 13C-urea breath test after eradication of Helicobacter pylori infection in Japan. J Gastroenterol Hepatol 2003;18:1379-83.
24. 13Carbon urea breath test for Helicobacter pylori: Comparison with histology, culture, and ELISA serology. Gut 1991;32:1461-4.
25. 13C urea tablet for the detection of Helicobacter pylori infection before and after treatment. Aliment Pharmacol Ther 2003;17:793-8.
26. 13C-urea. Eur J Gastroenterol Hepatol 1990;2:437-44.
27. 13C-urea breath test for the detection of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1991;3:915-21.
28. 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Comparison with histology.] Gastroenterol Clin Biol 1994; 18:1106-11.
29. 13C-urea breath test for Helicobacter pylori: Cut-off point determination by cluster analysis. Clin Sci (Lond) 1997;93:3-6.
30. Marshall JK, Armstrong D, O'Brien BJ. Test and treat strategies for Helicobacter pylori in uninvestigated dyspepsia: A Canadian economic analysis. Can J Gastroenterol 2000; 14:3 79-88.